Ruxolitinib and Chidamide Intensified Bu/CY Conditioning Regimen for Patients With Acute B Cell Lymphoblast Leukemia Underwenting Haploidenticl Peripheral Blood Stem Cell Transplantation
Latest Information Update: 05 Oct 2023
At a glance
- Drugs Busulfan (Primary) ; Carmustine (Primary) ; Cyclophosphamide (Primary) ; Cytarabine (Primary) ; Ruxolitinib (Primary) ; Tucidinostat (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 27 Oct 2021 New trial record